Management wasn't explicitly told but based on discussions its obvious what the FDA is after. Thus, Management has no requirement to tell shareholders and thus, can freely sell shares (personally and to fund the Company) at much higher prices than if it told shareholders.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.